Measuring Oxygen Levels in Heart Muscle During Open-Heart Surgery
Tests a device that measures oxygen levels in heart muscle during open-heart surgery.
Plain-language title generated from the registry record
Registry title: Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
Key facts
- Where
- Helsinki, FinlandSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT06084091, who can take part
Where in Finland
- Heart and Lung CenterHelsinki, FinlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Spectrocor
- Trial code
- NCT06084091
- Record updated
- 21 August 2026
- Original description
The goal of this observational study is to test in the safety and performance of intraoperative myocardial spectroscopic measurement in open-heart surgery patientsRead full original descriptionShow less
Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
The goal of this observational study is to test in the safety and performance of intraoperative myocardial spectroscopic measurement in open-heart surgery patients
The main questions it aims to answer are:
* The Devices can record myocardial spectrometric data for analysis, and * How these measures correlate with the occurring events, procedures, and clinical parameters during the operation. * Number of participants with device-related adverse events as assessed by CTCAE v4.0
Inclusion: Any 18 to 90-year-old patient scheduled for an open-heart operation; The ability to understand the study's objective and the risks involved; Informed consent obtained, including the agreement to authorization to use the protected personal patient records according to privacy legislation.
Exclusion: Inability to obtain an informed consent form; Patients included as vulnerable population according to Finnish Medical Research Act, including retarded, pregnant women, nursing mothers, prisoners, or forensic patients.